HuagongsheHuagongshe Chemistry Print Report · For research reference only
Dibenz(b,f)azepine → 9-[(2,4-Diaminothieno[2,3-d]pyrimidin-5-yl)methyl]dibenz[b,f]azepine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Dibenz(b,f)azepine | HCID 9212 | — |
| Reactant | n-[(2,4-Diaminothieno[2,3-d]pyrimidin-5-yl)methyl]-n,n-diphenylamine | HCID 9906281 | — |
| Reactant | Thieno[2,3-d]pyrimidine-2,4-diamine, 5-methyl- | HCID 12659534 | — |
| Product | 9-[(2,4-Diaminothieno[2,3-d]pyrimidin-5-yl)methyl]dibenz[b,f]azepine | HCID 22062999 | — |
Reaction Steps
9-[(2,4-Diaminothieno[2,3-d]pyrimidin-5-yl)methyl]dibenz[b,f]azepine (Formula I: Ar=2,4-diaminothieno[2,3-d]pyrimidin-5-yl; W=CH2; X=N; Z=CH═CH; m=n=0) is prepared similarly to N-[(2,4-diaminothieno[2,3-d]pyrimidin-5-yl)methyl]-N,N-diphenylamine as disclosed above by using 2,4-diamino-5-methylthieno[2,3-d]pyrimidine (1.3 g, 7.4 mmol) in Step 1 and dibenz[b,f]azepine (154 mg, 0.8 mmol) in Step 3. The final product and its intermediates can be purified by chromatography.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07056911B1 |
| Source dataset | uspto-grants-2006_06 |
| ORD ID | ord-a5ceaacddc34493ba4a9aef8ad7a62ec |
| Source note | uspto-grants-2006_06 |